• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial.

作者信息

Guo Yutao, Lip Gregory Yh

机构信息

Medical School of Chinese PLA, Department of Cardiology, Chinese PLA General Hospital, Beijing, China.

Liverpool Centre for Cardiovascular Sciences, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, UK.

出版信息

Arrhythm Electrophysiol Rev. 2020 Jun 3;9(1):5-7. doi: 10.15420/aer.2020.12.

DOI:10.15420/aer.2020.12
PMID:32637113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7330727/
Abstract
摘要

相似文献

1
Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial.心血管疾病的移动健康：房颤管理的新前沿：来自华为心脏研究和mAFA-II随机试验的观察结果
Arrhythm Electrophysiol Rev. 2020 Jun 3;9(1):5-7. doi: 10.15420/aer.2020.12.
2
Diagnostic Performance of a Smart Device With Photoplethysmography Technology for Atrial Fibrillation Detection: Pilot Study (Pre-mAFA II Registry).基于光电容积脉搏波技术的智能设备对心房颤动检测的诊断性能：初步研究（Pre-mAFA II 注册研究）
JMIR Mhealth Uhealth. 2019 Mar 5;7(3):e11437. doi: 10.2196/11437.
3
Population-Based Screening or Targeted Screening Based on Initial Clinical Risk Assessment for Atrial Fibrillation: A Report from the Huawei Heart Study.基于人群的房颤筛查或基于初始临床风险评估的靶向筛查：来自华为心脏研究的报告
J Clin Med. 2020 May 15;9(5):1493. doi: 10.3390/jcm9051493.
4
Mobile phones in cryptogenic strOke patients Bringing sIngle Lead ECGs for Atrial Fibrillation detection (MOBILE-AF): study protocol for a randomised controlled trial.隐匿性卒中患者使用手机进行单导联心电图房颤检测（MOBILE - AF）：一项随机对照试验的研究方案
Trials. 2017 Aug 29;18(1):402. doi: 10.1186/s13063-017-2131-0.
5
Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial.心房颤动的综合管理，包括基层医疗中抗凝治疗的个体化：ALL-IN整群随机试验的研究设计
BMJ Open. 2017 Sep 18;7(9):e015510. doi: 10.1136/bmjopen-2016-015510.
6
Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial.用于房颤管理的移动健康技术：整合决策支持、教育与患者参与——mAF应用试验
Am J Med. 2017 Dec;130(12):1388-1396.e6. doi: 10.1016/j.amjmed.2017.07.003. Epub 2017 Aug 26.
7
The last frontier in cardiovascular health: a landmark lecture for the XVII World Congress of the International Society for Heart Research.心血管健康的最后前沿：国际心脏研究学会第十七届世界大会的一场具有里程碑意义的讲座。
J Mol Cell Cardiol. 2001 Dec;33(12):2063-9. doi: 10.1006/jmcc.2001.1479.
8
Feasibility of Atrial Fibrillation Screening With Mobile Health Technologies at Pharmacies.利用移动健康技术在药房进行房颤筛查的可行性
J Cardiovasc Pharmacol Ther. 2020 Mar;25(2):142-151. doi: 10.1177/1074248419879089. Epub 2019 Oct 2.
9
Telemedical Interventional Management in Heart Failure II (TIM-HF2), a randomised, controlled trial investigating the impact of telemedicine on unplanned cardiovascular hospitalisations and mortality in heart failure patients: study design and description of the intervention.远程心脏病介入管理在心力衰竭 II 期（TIM-HF2）试验，一项随机对照试验，旨在研究远程医疗对心力衰竭患者非计划性心血管住院和死亡率的影响：研究设计和干预措施描述。
Eur J Heart Fail. 2018 Oct;20(10):1485-1493. doi: 10.1002/ejhf.1300. Epub 2018 Sep 19.
10
Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).地高辛在伴有不良心血管结局的心房颤动患者中的应用：利伐沙班每日一次口服直接 Xa 因子抑制剂与维生素 K 拮抗剂预防心房颤动卒中及栓塞的临床试验（ROCKET AF）的回顾性分析。
Lancet. 2015 Jun 13;385(9985):2363-70. doi: 10.1016/S0140-6736(14)61836-5. Epub 2015 Mar 6.

引用本文的文献

1
Advancements in Sensor Technology for Monitoring and Management of Chronic Coronary Syndrome.用于慢性冠状动脉综合征监测与管理的传感器技术进展
Sensors (Basel). 2025 Jul 24;25(15):4585. doi: 10.3390/s25154585.
2
Accuracy, Usability, and Adherence of Smartwatches for Atrial Fibrillation Detection in Older Adults After Stroke: Randomized Controlled Trial.智能手表用于中风后老年人房颤检测的准确性、可用性和依从性：随机对照试验
JMIR Cardio. 2023 Nov 28;7:e45137. doi: 10.2196/45137.
3
Remote Cardiac Rhythm Monitoring in the Era of Smart Wearables: Present Assets and Future Perspectives.智能可穿戴设备时代的远程心律监测：当前资源与未来展望
Front Cardiovasc Med. 2022 Mar 1;9:853614. doi: 10.3389/fcvm.2022.853614. eCollection 2022.

本文引用的文献

1
Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation.移动医疗技术改善房颤患者的护理。
J Am Coll Cardiol. 2020 Apr 7;75(13):1523-1534. doi: 10.1016/j.jacc.2020.01.052.
2
The household economic burden of non-communicable diseases in 18 countries.18 个国家的非传染性疾病家庭经济负担
BMJ Glob Health. 2020 Feb 11;5(2):e002040. doi: 10.1136/bmjgh-2019-002040. eCollection 2020.
3
Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial.基层医疗中房颤的综合管理：ALL-IN整群随机试验的结果
Eur Heart J. 2020 Aug 7;41(30):2836-2844. doi: 10.1093/eurheartj/ehaa055.
4
Validation of Single Centre Pre-Mobile Atrial Fibrillation Apps for Continuous Monitoring of Atrial Fibrillation in a Real-World Setting: Pilot Cohort Study.单中心移动前心房颤动应用程序在真实环境中持续监测心房颤动的验证：试点队列研究
J Med Internet Res. 2019 Dec 3;21(12):e14909. doi: 10.2196/14909.
5
Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation.大规模评估智能手表以识别心房颤动。
N Engl J Med. 2019 Nov 14;381(20):1909-1917. doi: 10.1056/NEJMoa1901183.
6
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation.利用移动光电容积脉搏波技术检测心房颤动。
J Am Coll Cardiol. 2019 Nov 12;74(19):2365-2375. doi: 10.1016/j.jacc.2019.08.019. Epub 2019 Sep 2.
7
Smartwatch Performance for the Detection and Quantification of Atrial Fibrillation.智能手表在心房颤动检测和量化中的性能。
Circ Arrhythm Electrophysiol. 2019 Jun;12(6):e006834. doi: 10.1161/CIRCEP.118.006834.
8
Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial.移动医疗（mHealth）技术在改善心房颤动筛查、患者参与和优化综合护理中的应用：mAFA（mAF-App）II 随机试验。
Int J Clin Pract. 2019 Jul;73(7):e13352. doi: 10.1111/ijcp.13352. Epub 2019 Jun 3.
9
Diagnostic Performance of a Smart Device With Photoplethysmography Technology for Atrial Fibrillation Detection: Pilot Study (Pre-mAFA II Registry).基于光电容积脉搏波技术的智能设备对心房颤动检测的诊断性能：初步研究（Pre-mAFA II 注册研究）
JMIR Mhealth Uhealth. 2019 Mar 5;7(3):e11437. doi: 10.2196/11437.
10
Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.抗栓治疗心房颤动：CHEST 指南和专家报告。
Chest. 2018 Nov;154(5):1121-1201. doi: 10.1016/j.chest.2018.07.040. Epub 2018 Aug 22.